CANDEL THERAPEUTICS, INC. (CADL) Shareholders’ equity 2021–2023
CANDEL THERAPEUTICS, INC. (CADL) shareholders’ equity at each fiscal year-end, per SEC filings.
$47.7MFY2023 · since FY2021: -$23.6M → $47.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $47.7M | -25.6% |
| FY2022 | $64.1M | +372.2% |
| FY2021 | -$23.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice